Viewing Study NCT04912856


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-01-01 @ 10:22 AM
Study NCT ID: NCT04912856
Status: TERMINATED
Last Update Posted: 2025-02-14
First Post: 2021-05-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE
Sponsor: Xenon Pharmaceuticals Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-08-17
Start Date Type: ACTUAL
Primary Completion Date: 2023-11-17
Primary Completion Date Type: ACTUAL
Completion Date: 2023-11-17
Completion Date Type: ACTUAL
First Submit Date: 2021-05-03
First Submit QC Date: None
Study First Post Date: 2021-06-03
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-11-15
Results First Submit QC Date: None
Results First Post Date: 2025-02-14
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-02-12
Last Update Post Date: 2025-02-14
Last Update Post Date Type: ACTUAL